Showing results (301-310 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 27, 2022
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future NeedsAndrew Lofts, Fahed Abu-Hijleh, Nicolette Rigg, et al.CNS Drugs|June 27, 2022
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant SchizophreniaC U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.CNS Drugs|January 11, 2021
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic StrokeAnil Gulati, Nilesh Agrawal, Deepti Vibha, et al.CNS Drugs|February 14, 2020
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's DiseaseLucia Caffino, Francesca Mottarlini, Fabio FumagalliCNS Drugs|February 16, 2020
Targeting BKCa Channels in Migraine: Rationale and PerspectivesMohammad Al-Mahdi Al-Karagholi, Christian Gram, Cherie Amalie Waldorff Nielsen, et al.CNS Drugs|March 6, 2020
Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of ResearchNada A Elsayed, Kaila M Yamamoto, Tanya E FroehlichCNS Drugs|July 6, 2021
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)Stanley L Cohan, Barry A Hendin, Anthony T Reder, et al.CNS Drugs|January 21, 2014
Potential role of N-acetylcysteine in the management of substance use disordersErin A McClure, Cassandra D Gipson, Robert J Malcolm, et al.CNS Drugs|May 22, 2014
Vitamin supplementation in the treatment of schizophreniaHannah E Brown, Joshua L RoffmanPageof 211